1. Home
  2. LITB vs IPSC Comparison

LITB vs IPSC Comparison

Compare LITB & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LITB
  • IPSC
  • Stock Information
  • Founded
  • LITB 2007
  • IPSC 2019
  • Country
  • LITB Singapore
  • IPSC United States
  • Employees
  • LITB N/A
  • IPSC N/A
  • Industry
  • LITB Catalog/Specialty Distribution
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • LITB Consumer Discretionary
  • IPSC Health Care
  • Exchange
  • LITB Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • LITB 38.0M
  • IPSC 43.6M
  • IPO Year
  • LITB N/A
  • IPSC 2021
  • Fundamental
  • Price
  • LITB $2.00
  • IPSC $0.51
  • Analyst Decision
  • LITB
  • IPSC Strong Buy
  • Analyst Count
  • LITB 0
  • IPSC 5
  • Target Price
  • LITB N/A
  • IPSC $3.33
  • AVG Volume (30 Days)
  • LITB 69.5K
  • IPSC 526.9K
  • Earning Date
  • LITB 09-09-2025
  • IPSC 11-04-2025
  • Dividend Yield
  • LITB N/A
  • IPSC N/A
  • EPS Growth
  • LITB N/A
  • IPSC N/A
  • EPS
  • LITB 0.12
  • IPSC N/A
  • Revenue
  • LITB $220,656,000.00
  • IPSC $114,128,000.00
  • Revenue This Year
  • LITB N/A
  • IPSC $1,589.94
  • Revenue Next Year
  • LITB N/A
  • IPSC N/A
  • P/E Ratio
  • LITB $17.13
  • IPSC N/A
  • Revenue Growth
  • LITB N/A
  • IPSC 5491.77
  • 52 Week Low
  • LITB $0.91
  • IPSC $0.34
  • 52 Week High
  • LITB $3.33
  • IPSC $1.86
  • Technical
  • Relative Strength Index (RSI)
  • LITB 67.10
  • IPSC 47.68
  • Support Level
  • LITB $2.02
  • IPSC $0.48
  • Resistance Level
  • LITB $2.32
  • IPSC $0.52
  • Average True Range (ATR)
  • LITB 0.24
  • IPSC 0.02
  • MACD
  • LITB 0.05
  • IPSC 0.00
  • Stochastic Oscillator
  • LITB 72.17
  • IPSC 79.31

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: